|
|
|
| |
|
|
| |
The latest drug discovery news from News Medical |
|
|
|
 | | |
 New Chemistries to Solve Drug Discovery Problems
From conjugation and delivery to scaffold innovation and fluorescent probe design, Frontier’s new PEG, oxaborole, and BODIPY dye lines support critical drug discovery workflows. Learn how these compounds improve assay design, expand medicinal chemistry options, and accelerate research decisions.
| |
|
|
|
|
| | |  Understanding drug resistance is crucial. Quantum modeling offers insights into molecular interactions, enhancing drug discovery and therapeutic strategies. | | | | |  Peptide-oligonucleotide conjugates enhance nucleic acid therapeutics, improving delivery and targeting for precision medicine and gene therapy applications. | | | | |  SyntheMol-RL integrates reinforcement learning for antibiotic design, producing synthesizable candidates that show efficacy against MRSA in preclinical models. | | | | |  Calla Lily Clinical Care, a women’s health-focused medical technology company, today announced dosing of the first patients in the FREEDOM clinical trial. | | | | |  A phase 2 human clinical trial of an antigen for a parasitic infection caused by hookworms has been shown to be effective in limiting the intensity of infection, paving the way for the development of a vaccine. | | | | |  JMIR Publications today featured a critical new story in its News and Perspectives section examining the recent waves of disruption to inclusive clinical trials and the emerging strategies to keep health equity on track. | |
|
|
|
 | | | How would you rate today's newsletter?
| |
|
|
|
| | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
_(12)__639136538353664439_multisizecolor_0_custom.jpg)
